These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36548390)

  • 1. Design and Evaluation of [
    Liu L; Johnson PD; Prime ME; Khetarpal V; Brown CJ; Anzillotti L; Bertoglio D; Chen X; Coe S; Davis R; Dickie AP; Esposito S; Gadouleau E; Giles PR; Greenaway C; Haber J; Halldin C; Haller S; Hayes S; Herbst T; Herrmann F; Heßmann M; Hsai MM; Khani Y; Kotey A; Lembo A; Mangette JE; Marriner GA; Marston RW; Mills MR; Monteagudo E; Forsberg-Morén A; Nag S; Orsatti L; Sandiego C; Schaertl S; Sproston J; Staelens S; Tookey J; Turner PA; Vecchi A; Veneziano M; Muñoz-Sanjuan I; Bard J; Dominguez C
    J Med Chem; 2023 Jan; 66(1):641-656. PubMed ID: 36548390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterization of mutant huntingtin aggregate-directed PET imaging tracer candidates.
    Herrmann F; Hessmann M; Schaertl S; Berg-Rosseburg K; Brown CJ; Bursow G; Chiki A; Ebneth A; Gehrmann M; Hoeschen N; Hotze M; Jahn S; Johnson PD; Khetarpal V; Kiselyov A; Kottig K; Ladewig S; Lashuel H; Letschert S; Mills MR; Petersen K; Prime ME; Scheich C; Schmiedel G; Wityak J; Liu L; Dominguez C; Muñoz-Sanjuán I; Bard JA
    Sci Rep; 2021 Sep; 11(1):17977. PubMed ID: 34504195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vivo Cerebral Imaging of Mutant Huntingtin Aggregates Using
    Bertoglio D; Weiss AR; Liguore W; Martin LD; Hobbs T; Templon J; Srinivasan S; Dominguez C; Munoz-Sanjuan I; Khetarpal V; Verhaeghe J; Staelens S; Link J; Liu L; Bard JA; McBride JL
    J Nucl Med; 2023 Oct; 64(10):1581-1587. PubMed ID: 37591545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [
    Liu L; Johnson PD; Prime ME; Khetarpal V; Lee MR; Brown CJ; Chen X; Clark-Frew D; Coe S; Conlon M; Davis R; Ensor S; Esposito S; Moren AF; Gai X; Green S; Greenaway C; Haber J; Halldin C; Hayes S; Herbst T; Herrmann F; Heßmann M; Hsai MM; Kotey A; Mangette JE; Mills MR; Monteagudo E; Nag S; Nibbio M; Orsatti L; Schaertl S; Scheich C; Sproston J; Stepanov V; Varnäs K; Varrone A; Wityak J; Mrzljak L; Munoz-Sanjuan I; Bard JA; Dominguez C
    J Med Chem; 2021 Aug; 64(16):12003-12021. PubMed ID: 34351166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging Mutant Huntingtin Aggregates: Development of a Potential PET Ligand.
    Liu L; Prime ME; Lee MR; Khetarpal V; Brown CJ; Johnson PD; Miranda-Azpiazu P; Chen X; Clark-Frew D; Coe S; Davis R; Dickie A; Ebneth A; Esposito S; Gadouleau E; Gai X; Galan S; Green S; Greenaway C; Giles P; Halldin C; Hayes S; Herbst T; Herrmann F; Heßmann M; Jia Z; Kiselyov A; Kotey A; Krulle T; Mangette JE; Marston RW; Menta S; Mills MR; Monteagudo E; Nag S; Nibbio M; Orsatti L; Schaertl S; Scheich C; Sproston J; Stepanov V; Svedberg M; Takano A; Taylor M; Thomas W; Toth M; Vaidya D; Vanräs K; Weddell D; Wigginton I; Wityak J; Mrzljak L; Munoz-Sanjuan I; Bard JA; Dominguez C
    J Med Chem; 2020 Aug; 63(15):8608-8633. PubMed ID: 32662649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a ligand for in vivo imaging of mutant huntingtin in Huntington's disease.
    Bertoglio D; Bard J; Hessmann M; Liu L; Gärtner A; De Lombaerde S; Huscher B; Zajicek F; Miranda A; Peters F; Herrmann F; Schaertl S; Vasilkovska T; Brown CJ; Johnson PD; Prime ME; Mills MR; Van der Linden A; Mrzljak L; Khetarpal V; Wang Y; Marchionini DM; Skinbjerg M; Verhaeghe J; Dominguez C; Staelens S; Munoz-Sanjuan I
    Sci Transl Med; 2022 Feb; 14(630):eabm3682. PubMed ID: 35108063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET Ligands for Imaging Mutant Huntingtin Aggregates: A Case Study in Non-For-Profit Scientific Management.
    Dickmann CGF; Milicevic Sephton S; Barker RA; Aigbirhio FI
    Chembiochem; 2024 Jun; 25(11):e202400152. PubMed ID: 38695673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodistribution and dosimetry in human healthy volunteers of the PET radioligands [
    Delva A; Koole M; Serdons K; Bormans G; Liu L; Bard J; Khetarpal V; Dominguez C; Munoz-Sanjuan I; Wood A; Skinbjerg M; Wang Y; Vandenberghe W; Van Laere K
    Eur J Nucl Med Mol Imaging; 2022 Dec; 50(1):48-60. PubMed ID: 36001116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal preclinical evaluation of the novel radioligand [11C]CHDI-626 for PET imaging of mutant huntingtin aggregates in Huntington's disease.
    Bertoglio D; Verhaeghe J; Miranda A; Wyffels L; Stroobants S; Mrzljak L; Khetarpal V; Skinbjerg M; Liu L; Dominguez C; Munoz-Sanjuan I; Bard J; Staelens S
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1166-1175. PubMed ID: 34651228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and Evaluation of a Fluorine-18 Radioligand for Imaging Huntingtin Aggregates by Positron Emission Tomographic Imaging.
    Kaur T; Brooks AF; Lapsys A; Desmond TJ; Stauff J; Arteaga J; Winton WP; Scott PJH
    Front Neurosci; 2021; 15():766176. PubMed ID: 34924935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis.
    Onur TS; Laitman A; Zhao H; Keyho R; Kim H; Wang J; Mair M; Wang H; Li L; Perez A; de Haro M; Wan YW; Allen G; Lu B; Al-Ramahi I; Liu Z; Botas J
    Elife; 2021 Apr; 10():. PubMed ID: 33871358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Imaging Biomarkers for Huntington's Disease and Other Hereditary Choreas.
    Fazio P; Paucar M; Svenningsson P; Varrone A
    Curr Neurol Neurosci Rep; 2018 Oct; 18(12):85. PubMed ID: 30291526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gedunin Degrades Aggregates of Mutant Huntingtin Protein and Intranuclear Inclusions via the Proteasomal Pathway in Neurons and Fibroblasts from Patients with Huntington's Disease.
    Yang W; Xie J; Qiang Q; Li L; Lin X; Ren Y; Ren W; Liu Q; Zhou G; Wei W; Saiyin H; Ma L
    Neurosci Bull; 2019 Dec; 35(6):1024-1034. PubMed ID: 31432317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of Small Molecules that Induce the Degradation of Huntingtin.
    Tomoshige S; Nomura S; Ohgane K; Hashimoto Y; Ishikawa M
    Angew Chem Int Ed Engl; 2017 Sep; 56(38):11530-11533. PubMed ID: 28703441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gossypol, a novel modulator of VCP, induces autophagic degradation of mutant huntingtin by promoting the formation of VCP/p97-LC3-mHTT complex.
    Li XJ; Zhang YY; Fu YH; Zhang H; Li HX; Li QF; Li HL; Tan RK; Jiang CX; Jiang W; Li ZX; Luo C; Lu BX; Dang YJ
    Acta Pharmacol Sin; 2021 Oct; 42(10):1556-1566. PubMed ID: 33495516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fractionation for Resolution of Soluble and Insoluble Huntingtin Species.
    Ochaba J; Morozko EL; O'Rourke JG; Thompson LM
    J Vis Exp; 2018 Feb; (132):. PubMed ID: 29553509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of GSK-3 ameliorates the pathogenesis of Huntington's disease.
    Rippin I; Bonder K; Joseph S; Sarsor A; Vaks L; Eldar-Finkelman H
    Neurobiol Dis; 2021 Jul; 154():105336. PubMed ID: 33753290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vivo Multidimensional Brain Imaging in Huntington's Disease Animal Models.
    Flament J; Hantraye P; Valette J
    Methods Mol Biol; 2018; 1780():285-301. PubMed ID: 29856025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-27a reduces mutant hutingtin aggregation in an in vitro model of Huntington's disease.
    Ban JJ; Chung JY; Lee M; Im W; Kim M
    Biochem Biophys Res Commun; 2017 Jun; 488(2):316-321. PubMed ID: 28495533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant Huntingtin Inhibits αB-Crystallin Expression and Impairs Exosome Secretion from Astrocytes.
    Hong Y; Zhao T; Li XJ; Li S
    J Neurosci; 2017 Sep; 37(39):9550-9563. PubMed ID: 28893927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.